59.87
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Morgan Stanley stock is traded at $59.87, with a volume of 3,994.
It is down -1.11% in the last 24 hours and up +11.54% over the past month.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
See More
Previous Close:
$60.64
Open:
$60.02
24h Volume:
3,994
Relative Volume:
0.01
Market Cap:
$3.16B
Revenue:
$5.32B
Net Income/Loss:
$373.28M
P/E Ratio:
8.9677
EPS:
6.6762
Net Cash Flow:
$371.99M
1W Performance:
+0.49%
1M Performance:
+11.54%
6M Performance:
-36.50%
1Y Performance:
-18.81%
Morgan Stanley Stock (MMS) Company Profile
Name
Morgan Stanley
Sector
Industry
Phone
(703) 251-8500
Address
ATTN: TREASURY DEPT., MCLEAN, VA
Compare MMS vs MS, GS, SCHW, HOOD, IBKR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MMS
Morgan Stanley
|
60.11 | 3.20B | 5.32B | 373.28M | 371.99M | 6.6762 |
|
MS
Morgan Stanley
|
211.50 | 337.29B | 128.77B | 20.37B | 39.02B | 12.37 |
|
GS
Goldman Sachs Group Inc
|
1,034.22 | 309.24B | 128.57B | 20.97B | 112.72B | 64.79 |
|
SCHW
Charles Schwab Corp
|
104.30 | 181.18B | 28.33B | 9.42B | 9.76B | 5.0426 |
|
HOOD
Robinhood Markets Inc
|
88.68 | 85.87B | 4.65B | 1.89B | -2.09B | 2.0676 |
|
IBKR
Interactive Brokers Group Inc
|
91.44 | 41.10B | 10.76B | 4.56B | 35.82B | 2.326 |
Morgan Stanley Stock (MMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-02-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-18-23 | Initiated | Stifel | Buy |
| Jun-28-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-08-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Jun-24-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Aug-09-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-08-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Feb-08-18 | Reiterated | Maxim Group | Hold |
| May-25-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| May-05-17 | Downgrade | Jefferies | Buy → Hold |
| May-04-17 | Downgrade | Maxim Group | Buy → Hold |
| Apr-07-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-15-16 | Downgrade | Sidoti | Buy → Neutral |
| Nov-09-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Maxim Group | Buy |
| Feb-04-16 | Reiterated | Maxim Group | Buy |
| Feb-01-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-04-15 | Initiated | Stifel | Buy |
| Nov-12-15 | Reiterated | Maxim Group | Buy |
| Aug-20-15 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-15 | Reiterated | Maxim Group | Buy |
| May-07-15 | Reiterated | Maxim Group | Buy |
| Feb-05-15 | Reiterated | Maxim Group | Buy |
View All
Morgan Stanley Stock (MMS) Latest News
Wall Street’s Trading Boom Just Got a New Leader: Can Morgan Stanley (MS) Keep It? - Yahoo Finance UK
Morgan Stanley launches ETH, Solana ETFs at 0.14% - Crypto News
Morgan Stanley Launches 0.14% Ethereum and Solana ETFs: Will Flows Follow? - Yahoo Finance
Philadelphia Semiconductor Index Falls Over 5% and SanDisk Drops Over 15% as Software Stocks Buck Trend After Morgan Stanley Says They Are Oversold - TradingKey
Morgan Stanley Debuts Lowest-Cost Ethereum, Solana ETFsMorgan Stanley Ethereum Trust (ARCA:MSSE), Morg - Benzinga
F5 Fiscal Q3 Exceeded Expectations on Systems, Gross Margin Upside, Morgan Stanley Says - marketscreener.com
Morgan Stanley rolls out new crypto funds that reward you for holding - thestreet.com
Morgan Stanley launches low-cost ether and sola... - Pluang
Morgan Stanley expands ETP line with Ethereum, Solana products (MS:NYSE) - Seeking Alpha
Morgan Stanley launches low-fee Ethereum and So... - Pluang
MU, AMD, INTC, SNDK Stocks Fall — Morgan Stanley's Mike Wilson Explains Why Investors Are Going After Chip And Memory Stocks - Yahoo Finance
Morgan Stanley Launches Ethereum and Solana ETFs Following NYSE Arca Approval - CoinGape
Morgan Stanley Investment Management Selects Figment as a Staking Provider for Its New Ether and SOL ETPs - Business Wire
Morgan Stanley debuts ether, solana exchange-traded products after bitcoin fund success - CoinDesk
Morgan Stanley debuts Ethereum and Solana ETFs with market's lowest fee, staking rewards - The Block
Morgan Stanley launches low-cost Ethereum and S... - Pluang
Citi hires Morgan Stanley veteran Rob Lunn as it ramps up investment management - InvestmentNews
Veolia slips, Morgan Stanley sees limited upside potential - marketscreener.com
Morgan Stanley Expands Crypto ETF Suite With New Ethereum & Solana Trusts - ETF Trends
Morgan Stanley Investment Management Expands ETP Offerings With Launch of Ethereum and Solana Exchange-Traded Products - marketscreener.com
Morgan Stanley Backs This Stock on Improving Growth, Margin Recovery By Investing.com - Investing.com Canada
Morgan Stanley Reaffirms "Equal Weight" Rating for Maplight Therapeutics (NASDAQ:MPLT) - MarketBeat
Morgan Stanley Estimates GenAI ROIC at 25%-50%, Providing Strong Backing for Inference-Era Capex Logic - finance.biggo.com
The numbers add up! Morgan Stanley: In the age of reasoning, generative AI could deliver a return on capital of 25–50%. - Moomoo
Morgan Stanley raises Corpay stock price target on growth outlook - Investing.com
Morgan Stanley raises Datadog stock price target on growth momentum - Investing.com
Morgan Stanley Adjusts Price Target on Datadog to $300 From $225, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Downgrades MapLight Therapeutics to Equalweight From Overweight, $34 PT - marketscreener.com
Morgan Stanley Adjusts PT on Cadence Design Systems to $400 From $370, Maintains Overweight Rating - marketscreener.com
Morgan Stanley's Mike Wilson: Still very constructive on where the S&P 500 ends up for the full year - CNBC
Morgan Stanley says SpaceX at $100 would imply zero AI value after stock plunges roughly 50% from post-IPO high - Yahoo! Finance Canada
Morgan Stanley raises Corpay stock price target on growth outlook By Investing.com - Investing.com Canada
Investors expect SpaceX to slide to $100 per share which suggests zero AI business value - moneywise.com
Morgan Stanley leads construction M&A advisory in H1 2026 - World Construction Network
Morgan Stanley says load up on these 13 AI power infrastructure stocks — including 2 'standout' energy storage plays - AOL.com
Morgan Stanley Adjusts Price Target on Corpay to $415 From $400, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on F5 to $415 From $380, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Navitas Semiconductor to $12.60 From $13.70, Keeps Underweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Amkor Technology to $70 From $69, Maintains Equalweight Rating - marketscreener.com
Conversica Receives Investment From Morgan Stanley Expansion Capital - FinSMEs
REGIntnl Personal Fin Morgan StanleyHolding(s) in Company - TradingView
SpaceX selloff implies zero value for AI business: Morgan Stanley - ETEnterpriseai.com
Strong earnings, record highs – so why is Wall Street stuck? - The Australian
France analyst views: LVMH gets tongues wagging, Morgan Stanley downgrades Veolia - marketscreener.com
Morgan Stanley Names Top Picks in Japan’s Space Sector - Investing.com
Morgan Stanley raises SSAB price target to 115 kronor (100), reiterates overweightBN - marketscreener.com
Morgan Stanley rates TCL as Equal-weight - marketscreener.com
‘Don’t Get Too Excited,’ Says Morgan Stanley About Applied Digital Stock - TipRanks
Morgan Stanley sees a troubling S&P 500 repeat - thestreet.com
AI Adopters Could Boost Net Margins by One Percentage Point by 2027, Morgan Stanley Says - Briefs Finance
Morgan Stanley downgrades MapLight Therapeutics stock rating on trial results - Investing.com Canada
Morgan Stanley Stock (MMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):